XML 37 R21.htm IDEA: XBRL DOCUMENT v3.20.4
Intangible assets
12 Months Ended
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible assets Intangible assetsIntangible assets, net of accumulated amortization, are summarized as follows (in thousands):
As of December 31,As of December 31,
20202019
CostAccumulated amortizationNetCostAccumulated amortizationNet
Developed technology$30,100 $(24,456)$5,644 $30,100 $(20,694)$9,406 
In-licensed rights5,224 (827)4,397 5,224 (304)4,920 
Total$35,324 $(25,283)$10,041 $35,324 $(20,998)$14,326 
Amortization expense for intangible assets was $4.3 million, $4.1 million, and $3.8 million for each of the years ended December 31, 2020, 2019 and 2018, respectively.
Developed technology
The Company's developed technology was obtained through its acquisition of Pregenen, a privately-held biotechnology company in 2014. The Company obtained gene editing and cell signaling technology with a broad range of potential therapeutic applications. The Company considered the intangible asset acquired to be developed technology, as at the date of the acquisition it could be used the way it was intended to be used in certain ongoing research and development activities. The gene editing platform intangible asset is being amortized on a straight-line basis over its expected useful life of approximately eight years from the date of the acquisition. Please refer to Note 4, Fair value measurements, and Note 9, Commitments and contingencies, for further information.
In-licensed rights
In-licensed rights consist of capitalized milestone payments made to third parties upon receiving regulatory approval of ZYNTEGLO in the EU. The in-licensed rights are being amortized on a straight-line basis over the remaining life of the related patents of approximately ten years, as the life of the related patents reflects the expected time period that the Company will benefit from the in-licensed rights.
The following table summarizes the estimated future amortization for intangible assets for the next five years and thereafter (in thousands):
As of December 31, 2020
2021$4,285 
20222,404 
2023522 
2024522 
2025522 
2026 and thereafter1,786 
Total$10,041